Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Dimier-Poisson

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
European Journal of Medicinal Chemistry|October 20, 2015
Development of new highly potent imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1Espérance Moine, Isabelle Dimier-Poisson, Cécile Enguehard-Gueiffier, et al.
Journal for Immunotherapy of Cancer|May 16, 2023
Nasal administration of recombinant <i>Neospora caninum</i> secreting IL-15/IL-15Rα inhibits metastatic melanoma development in lungArthur Battistoni, Louis Lantier, Anne di Tommaso, et al.
International Journal for Parasitology|March 30, 2023
Vaccination of squirrel monkeys (Saimiri spp.) with nanoparticle-based Toxoplasma gondii antigens: new hope for captive susceptible speciesCéline Ducournau, Pauline Cantin, Vanessa Alerte, et al.
Journal for Immunotherapy of Cancer|December 1, 2020
<i>Neospora caninum:</i> a new class of biopharmaceuticals in the therapeutic arsenal against cancerLouis Lantier, Agathe Poupée-Beaugé, Anne di Tommaso, et al.
NPJ Vaccines|April 18, 2025
Intranasal spike and nucleoprotein fusion protein-based vaccine provides cross-protection and reduced transmission against SARS-CoV-2 variantsZineb Lakhrif, Agathe Poupée-Beaugé, Fanny Boursin, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
European Journal of Medicinal Chemistry|October 20, 2015
Development of new highly potent imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1Espérance Moine, Isabelle Dimier-Poisson, Cécile Enguehard-Gueiffier, et al.
Journal for Immunotherapy of Cancer|May 16, 2023
Nasal administration of recombinant <i>Neospora caninum</i> secreting IL-15/IL-15Rα inhibits metastatic melanoma development in lungArthur Battistoni, Louis Lantier, Anne di Tommaso, et al.
International Journal for Parasitology|March 30, 2023
Vaccination of squirrel monkeys (Saimiri spp.) with nanoparticle-based Toxoplasma gondii antigens: new hope for captive susceptible speciesCéline Ducournau, Pauline Cantin, Vanessa Alerte, et al.
Journal for Immunotherapy of Cancer|December 1, 2020
<i>Neospora caninum:</i> a new class of biopharmaceuticals in the therapeutic arsenal against cancerLouis Lantier, Agathe Poupée-Beaugé, Anne di Tommaso, et al.
NPJ Vaccines|April 18, 2025
Intranasal spike and nucleoprotein fusion protein-based vaccine provides cross-protection and reduced transmission against SARS-CoV-2 variantsZineb Lakhrif, Agathe Poupée-Beaugé, Fanny Boursin, et al.
Pageof 7